Enveric Biosciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$647
$0
Gross Profit
-84
-85
562
-95
EBITDA
-1,813
-2,391
-2,299
-2,740
EBIT
-1,897
-2,477
-2,384
-2,836
Net Income
-1,879
-2,456
-3,435
-2,822
Net Change In Cash
0
0
647
0
Free Cash Flow
-2,889
-2,598
-1,751
-2,740
Cash
3,502
6,356
2,287
4,266
Basic Shares
7,587
4,001
2,348
2,164

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$39,914
Gross Profit
-408
-435
-681
-120
EBITDA
-16
-19,526
-26,388
-6,419
EBIT
-16
-19,961
-27,069
-6,540
Net Income
-17
-18,471
-48,976
-6,386
Net Change In Cash
0
0
0
39,914
Free Cash Flow
-14,099
-17,730
-12,322
-3,932
Cash
2,287
17,723
17,355
1,578
Basic Shares
2
1,446
472
115

Earnings Calls

Quarter EPS
2024-06-30
-$0.25
2024-03-31
-$0.42
2023-12-31
-$1.47
2023-09-30
-$1.30